Jump Financial’s Vera Therapeutics VERA Stock Holding History

Jump Financial’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.01M	Buy	140,089 +58,537	+72%	+$2.18M	0.05%	443
2026 Q1	$3.28M	Buy	81,552 +75,559	+1,261%	+$3.26M	0.04%	469
2025 Q4	$303K	Sell	5,993 -48,360	-89%	-$1.72M	﹤0.01%	1558
2025 Q3	$1.58M	Sell	54,353 -90,953	-63%	-$2.1M	0.02%	818
2025 Q2	$3.42M	Buy	145,306 +107,587	+285%	+$2.42M	0.04%	543
2025 Q1	$906K	Buy	+37,719	New	+$1.21M	0.01%	866
2023 Q2	–	Sell	-52,700	Closed	-$409K	–	2183
2023 Q1	$409K	Buy	52,700 +35,100	+199%	+$271K	0.02%	986
2022 Q4	$341K	Buy	+17,600	New	+$319K	0.02%	968

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jump Financial's VERA Position: Q2 2026 in Review

Jump Financial increased its Vera Therapeutics (VERA) stake by 72% in Q2 2026, buying an estimated $2.18M and bringing the position to 140,089 shares worth $6.01M. The position accounts for 0.05% of the portfolio, ranked #443.

Jump Financial first reported a position in VERA in Q4 2022 and has held it in 8 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Jump Financial held 140,089 shares of Vera Therapeutics worth $6.01M as of Q2 2026.
Jump Financial bought 58,537 Vera Therapeutics shares in Q2 2026, an estimated $2.18M.
Vera Therapeutics made up 0.05% of Jump Financial's portfolio in Q2 2026, its #443 holding.
Jump Financial first reported a position in Vera Therapeutics in Q4 2022 and has held it in 8 quarters since.
219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.